Kingworld Medicines Group Company Description

Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products.

The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series brands.

It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceuticals, healthcare, general foodstuffs, and medical products.

In addition, the company is involved in the distribution and sale of artwork; organization of art exhibitions; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities.

It operates in the People’s Republic of China, Japan, the United States, Canada, Hong Kong, Taiwan, Thailand, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally.

The company was founded in 1996 and is headquartered in Shenzhen, the People’s Republic of China.

Kingworld Medicines Group Limited

Country	Cayman Islands
Founded	1996
Industry	Pharmaceutical Retailers
Sector	Healthcare
Employees	972
CEO	Li Sheng Zhao

Contact Details

Address: Majialong Chuangxin Building Shenzhen China
Phone	86 755 8229 2888
Website	kingworld.com.cn

Stock Details

Ticker Symbol	1110
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	KYG5268M1006
SIC Code	5122

Key Executives

Name	Position
Li Sheng Zhao	Co-Founder, Chairman and Chief Executive Officer
Lok San Chan	Co-Founder and Executive Director
Xuhua Zhou	Executive Director
Hon Wan Chan CA	Financial Controller and Company Secretary